The cost-effectiveness of ESBL detection: Towards molecular detection methods?

Clinical Microbiology and Infection

Volumn 19, Issue 7, 2013, Pages 662-665

  Wintermans, B B ^a   Reuland, E A ^a   Wintermans, R G F ^b   Bergmans, A M C ^b,c   Kluytmans, J A J W ^a,c  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b Medical Microbiology and Infection Control   (Netherlands)

^c Amphia Medical Center   (Netherlands)

Author keywords

Check Points; Cost effectiveness; ESBL; ESBL detection; Etest; Microarray

Indexed keywords

EXTENDED SPECTRUM BETA LACTAMASE;

ARTICLE; BACTERIUM ISOLATION; CITROBACTER FREUNDII; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; DIAGNOSTIC ACCURACY; DIAGNOSTIC EQUIPMENT; DIAGNOSTIC TEST ACCURACY STUDY; DOUBLE DISK CONFIRMATION TEST; ENTEROBACTER CLOACAE; ESCHERICHIA COLI; EXTENDED SPECTRUM BETA LACTAMASE PRODUCING ENTEROBACTERIACEAE; FALSE POSITIVE RESULT; GENOTYPING TECHNIQUE; HUMAN; INTERMETHOD COMPARISON; KLEBSIELLA OXYTOCA; KLEBSIELLA PNEUMONIAE; MAJOR CLINICAL STUDY; MICROARRAY ANALYSIS; MOLECULAR DIAGNOSIS; PHENOTYPE; POLYMERASE CHAIN REACTION; PREDICTIVE VALUE; PRIORITY JOURNAL; PROTEUS MIRABILIS; SEQUENCE ANALYSIS;

EID: 84878924783     PISSN: 1198743X     EISSN: 14690691     Source Type: Journal    
DOI: 10.1111/j.1469-0691.2012.03998.x     Document Type: Article

References (13)

1. Antimicrobial resistance surveillance in Europe Annual report of the European Antimicrobial Resistance Surveillance Network (EARS-Net); 2009. Available at: http://www.ecdc.europa.eu/en/publications/Publications/Forms/ECDC_DispForm.aspx?ID=580.
2. Bush K. Extended-spectrum beta-lactamases in North America, 1987-2006. Clin Microbiol Infect 2008; 14 (Suppl 1): 134-143.
3. Cantón R, Novais A, Valverde A et al. Prevalence and spread of extended-spectrum beta-lactamase-producing Enterobacteriaceae in Europe. Clin Microbiol Infect 2008; 14 (Suppl 1): 144-153.
4. Roberts RR, Hota B, Ahmad I et al. Hospital and societal costs of antimicrobial-resistant infections in a Chicago teaching hospital: implications for antibiotic stewardship. Clin Infect Dis 2009; 49: 1175-1184.
5. Paterson DL, Bonomo RA. Extended-spectrum beta-lactamases: a clinical update. Clin Microbiol Rev 2005; 18: 657-686.
6. Maatregelen tegen overdracht van bijzonder- resistente micro-organismen (BRMO). Available at: http://www.wip.nl/free_content/Richtlijnen/BRMO.pdf.
7. Cohen Stuart J, Dierikx C, Al Naiemi N et al. Rapid detection of TEM, SHV and CTX-M extended-spectrum beta-lactamases in Enterobacteriaceae using ligation-mediated amplification with microarray analysis. J Antimicrob Chemother 2010; 65: 1377-1381.
8. Endimiani A, Hujer AM, Hujer KM et al. Evaluation of a commercial microarray system for detection of SHV-, TEM-, CTX-M-, and KPC-type beta-lactamase genes in Gram-negative isolates. J Clin Microbiol 2010; 48: 2618-2622.
9. Naas T, Cuzon G, Truong H, Bernabeu S, Nordmann P. Evaluation of a DNA microarray, the check-points ESBL/KPC array, for rapid detection of TEM, SHV, and CTX-M extended-spectrum beta-lactamases and KPC carbapenemases. Antimicrob Agents Chemother 2010; 54: 3086-3092.
10. Willemsen I, Overdevest I, Al Naiemi N et al. New Diagnostic Microarray (Check-KPC ESBL) for Detection and Identification of Extended-Spectrum Beta-Lactamases in Highly Resistant Enterobacteriaceae. J Clin Microbiol 2011; 49: 2985-2987.
11. Platteel TN, Cohen Stuart J, Voets G et al. Evaluation of a commercial microarray as a confirmation test for the presence of extended-spectrum β-lactamases in isolates from the routine clinical setting. Clin Microbiol Infect 2011; 17: 1435-1438.
12. Bernards AT, Bonten MJ, Cohen J et al. NVMM-guideline Laboratory detection of highly resistant microorganisms (HRMO). Available at: http://www.nvmm.nl/richtlijnen/esbl-screening-en-confirmatie.
13. Naiemi NA, Duim B, Savelkoul PH et al. Widespread transfer of resistance genes between bacterial species in an intensive care unit: implications for hospital epidemiology. J Clin Microbiol 2005; 43: 4862-4864.